Pan-Lin Capital focuses on China's healthcare and deep tech sectors, aiming to back scientists who become entrepreneurs in areas like RNA-based therapeutics, medical devices, and hard-tech infrastructure such as photonic chips. Its team blends backgrounds in venture investing, asset management, and mining investment, and it has shown a pattern of staying invested over many rounds, including one company it backed through six funding rounds before it went public.